These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15901870)

  • 1. Recombinant activated factor VII for acute intracerebral hemorrhage.
    Friedrich JO
    N Engl J Med; 2005 May; 352(20):2133-4; author reply 2133-4. PubMed ID: 15901870
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage.
    Mayer SA; Brun NC; Begtrup K; Broderick J; Davis S; Diringer MN; Skolnick BE; Steiner T;
    N Engl J Med; 2008 May; 358(20):2127-37. PubMed ID: 18480205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant activated factor VII for acute intracerebral hemorrhage.
    Sheth KN
    N Engl J Med; 2005 May; 352(20):2133-4; author reply 2133-4. PubMed ID: 15906433
    [No Abstract]   [Full Text] [Related]  

  • 4. Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII.
    Steiner T; Diringer MN; Schneider D; Mayer SA; Begtrup K; Broderick J; Skolnick BE; Davis SM
    Neurosurgery; 2006 Oct; 59(4):767-73; discussion 773-4. PubMed ID: 17038942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant activated factor VII for acute intracerebral hemorrhage.
    Mayer SA; Brun NC; Begtrup K; Broderick J; Davis S; Diringer MN; Skolnick BE; Steiner T;
    N Engl J Med; 2005 Feb; 352(8):777-85. PubMed ID: 15728810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracerebral hemorrhage--improving outcome by reducing volume?
    Tuhrim S
    N Engl J Med; 2008 May; 358(20):2174-6. PubMed ID: 18480212
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acute treatment with recombinant factor VII is probably indicated for intracerebral haematoma].
    Rinkel GJ
    Ned Tijdschr Geneeskd; 2005 Aug; 149(33):1827-9. PubMed ID: 16128178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early recombinant activated factor VII for intracerebral hemorrhage reduced hematoma growth and mortality, while improving functional outcomes.
    Emlet LL; Crippen D
    Crit Care; 2006 Feb; 10(1):304. PubMed ID: 16420665
    [No Abstract]   [Full Text] [Related]  

  • 9. A meta-analysis of the efficacy and safety of recombinant activated factor VII for patients with acute intracerebral hemorrhage without hemophilia.
    Yuan ZH; Jiang JK; Huang WD; Pan J; Zhu JY; Wang JZ
    J Clin Neurosci; 2010 Jun; 17(6):685-93. PubMed ID: 20399668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant activated factor VII for acute intracerebral hemorrhage.
    Mayer SA
    Stroke; 2007 Feb; 38(2 Suppl):763-7. PubMed ID: 17261734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of recombinant activated factor VII on health-related quality of life after intracerebral hemorrhage.
    Diringer MN; Ferran JM; Broderick J; Davis S; Mayer SA; Steiner T; Brun NC; Skolnick BE; Christensen MC
    Cerebrovasc Dis; 2007; 24(2-3):219-25. PubMed ID: 17630481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical management of acute intracerebral hemorrhage.
    Anderson CS
    Curr Opin Crit Care; 2009 Apr; 15(2):93-8. PubMed ID: 19578319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage.
    Mayer SA; Brun NC; Broderick J; Davis S; Diringer MN; Skolnick BE; Steiner T;
    Stroke; 2005 Jan; 36(1):74-9. PubMed ID: 15569871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing the risk of ICH enlargement.
    Wartenberg KE; Mayer SA
    J Neurol Sci; 2007 Oct; 261(1-2):99-107. PubMed ID: 17631908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant factor VIIa for intracranial haemorrhage in a Jehovah's Witness with severe haemophilia A and factor VIII inhibitors.
    Majumdar G; Savidge GF
    Blood Coagul Fibrinolysis; 1993 Dec; 4(6):1031-3. PubMed ID: 8148476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant activated factor VII in the treatment of near-fatal bleeding during pediatric brain tumor surgery. Report of two cases and review of the literature.
    Hartmann M; Sucker C; Messing M
    J Neurosurg; 2006 Jan; 104(1 Suppl):55-8. PubMed ID: 16509483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemostatic treatment in the early stage of intracerebral hemorrhage: the recombinant factor VIIa experience.
    Kase CS
    Stroke; 2005 Oct; 36(10):2321-2. PubMed ID: 16151037
    [No Abstract]   [Full Text] [Related]  

  • 18. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage.
    Chang GY
    Neurology; 2007 Feb; 68(6):471-2; author reply 472. PubMed ID: 17283327
    [No Abstract]   [Full Text] [Related]  

  • 19. Stopping the bleeding in intracerebral hemorrhage.
    Brown DL; Morgenstern LB
    N Engl J Med; 2005 Feb; 352(8):828-30. PubMed ID: 15728817
    [No Abstract]   [Full Text] [Related]  

  • 20. Recombinant activated factor VII for bleeding in patients without inherited bleeding disorders.
    Selin S; Tejani A
    Issues Emerg Health Technol; 2006 Mar; (82):1-4. PubMed ID: 16602203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.